SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
BeOne Medicines Ltd.
@ONC_InsiderForm 4 Filing: Wang Lai Sells $296K of $ONC
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
BeOne Medicines Ltd.
Ticker: $ONC
Transaction Value
$296K
Price/Share: $276.74
transaction date
2026-06-23
Shares: 1,068
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wang Lai, holds the title of President, Global Head of R&D at BeOne Medicines Ltd..
On 2026-06-23, the insider transacted 1,068 shares.The shares were transacted at a weighted average price of $276.74 per share, resulting in a total market-relevant value of $296K.
Executive Summary Summary
Wang Lai (President, Global Head of R&D) sold $296K of $ONC
Post-Transaction Position: 0 shares
SEC Accession No: 0001852291-26-000007 (CIK: 1852291)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.